INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

75,408 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
VP
Villanova PatrickChief Financial Officer
BLBLACKLINE, INC.
Option exercise
M—
750 sh
Sep 2, 2026Sep 4, 2026
Page 504 of 1886
← PrevNext →
traded Sep 2, 2026
+2d
SEC Form 4

Evidence

9
TJ
Tarangelo James J.EVP and CFO
ARMKAramark
Option exercise
M—
8,852 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
BS
Ben Zvi ShmuelDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
17.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
FD
Frieson DonaldDirector
CASYCASEYS GENERAL STORES INC
Option exercise
M—
326 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
SJ
Schwartz Harold JDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
KT
Kempster ThomasDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
WM
Wessling Erin MEVP & Chief Legal Officer
ELVElevance Health, Inc.
Tax withholding
F$38K
94 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
NA
Newcomb George A.Chief Accounting Officer
GEHCGE HealthCare Technologies Inc.
Tax withholding
F$7,903
112 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
GA
Gilboa David AbrahamDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
44.6K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
CD
Collins John DeNeenCFO and COO
LPSNLIVEPERSON INC
Disposition to issuer
D—
6,260 sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
NY
Naos YaronSr. VP & COO
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
56.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
KJ
Kim JoyceDirector
QUIKQUICKLOGIC Corp
Option exercise
M—
5,246 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
BH
Baran Elizabeth H.SVP, General Counsel
DKSDICK'S SPORTING GOODS, INC.
Tax withholding
F$9,504
68 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
CR
Chambers RebeccaChief Financial Officer
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$106K
2,477 sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
SM
Spanos MikeDirector
CASYCASEYS GENERAL STORES INC
Option exercise
M—
326 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
SN
Stallone NancyDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
PJ
Pace Philip JSVP, Chief Accounting Officer
BLMNBloomin' Brands, Inc.
Option exercise
M—
15.4K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
FE
Forster EliotDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
17.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
EC
Estrampes CatherineChief Commer. & Growth Officer
GEHCGE HealthCare Technologies Inc.
Tax withholding
F$36K
508 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
MA
Mitchell Uwayne A.Director
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
GM
Grover MatthewDirector
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
WI
Wilson IanEXECUTIVE VICE PRESIDENT
AMCRAmcor plc
Option exercise
M—
5,782 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
TJ
Tjon Karin-JoyceDirector
LPSNLIVEPERSON INC
Disposition to issuer
D—
18.7K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

9
BD
Bashan DrorDirector, PRESIDENT AND CEO
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
320.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
MA
Maglione Lawrence A.Director
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
BD
Bashan DrorDirector, PRESIDENT AND CEO
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
160.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
BS
Ben Zvi ShmuelDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
8,500 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

9
WI
Wilson IanEXECUTIVE VICE PRESIDENT
AMCRAmcor plc
Tax withholding
F$24K
514 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
MA
Mitchell Uwayne A.Director
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
LK
Lefferts KellyEVP, Chief Legal Officer
BLMNBloomin' Brands, Inc.
Tax withholding
F$37K
3,747 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$317K
30.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
MA
Maglione Lawrence A.Director
DTSTData Storage Corp
Option exercise
M—
10.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

9
EC
Elze ChristianDirector
PLXProtalix BioTherapeutics, Inc.
Grant or award
A—
17.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

8
CC
Christel Eric CEVP, Chief Financial Officer
BLMNBloomin' Brands, Inc.
Tax withholding
F$61K
6,125 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

8
LJ
Leite JohnGlobal Chief Commercial Off
VCYTVERACYTE, INC.
Tax withholding
F$178K
3,961 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

8
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$650K
18.5K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

8
VJ
Vassil JonathanChief Revenue Officer
TOSTToast, Inc.
Open-market sale · 10b5-1 plan
SELL$171K
5,100 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

7
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
30.8K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

7
TB
Tighe BrettChief Financial Officer
OKTAOkta, Inc.
Derivative conversion · 10b5-1 plan
C—
41.3K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

7
GP
Gallagher Thomas P.Director, Chairman & CEO
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise · 10b5-1 plan
M—
4,464 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence